Clinical Trial: Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases
Brief Summary: To assess the safety and efficacy of a single fraction of radiotherapy using helical tomotherapy to treat bone metastases.
Detailed Summary:
Sponsor: Alberta Health Services
Current Primary Outcome: To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy
Original Primary Outcome: Same as current
Current Secondary Outcome:
- To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.
- To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.
- To determine the maximum tolerated does of palliative radiation give with helical tomotherapy in a single fraction.
- To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.
Original Secondary Outcome:
- To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.
- To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.
- To determine the maximum tolerated does of palliative radiation give with helical tomotherpay in a single fraction.
- To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.
Information By: AHS Cancer Control Alberta
Dates:
Date Received: September 9, 2005
Date Started: June 2001
Date Completion: July 2005
Last Updated: December 8, 2011
Last Verified: December 2011
